Despite recent advances in oral cancer treatment, the survival rates of affected patients are still low and do not exceed 60% globally five years after diagnosis.
ERYTHROPLAKIA OF THE ORAL CAVITY: a severe potentially malignant lesion.

Despite recent advances in oral cancer treatment, the survival rates of affected patients are still low and do not exceed 60% globally five years after diagnosis.